Breaking News
March 23, 2019 - Evoke Pharma Submits Response to FDA Review Letter for Gimoti NDA
March 23, 2019 - Tracking HIV’s ever-evolving genome in effort to prioritize public health resources
March 23, 2019 - Scientists grow most sophisticated brain organoid to date
March 23, 2019 - ADHD drug raising risk of psychosis
March 22, 2019 - FDA approves brexanolone, first drug developed to treat postpartum depression
March 22, 2019 - Gruesome cat and dog experiments by the USDA exposed
March 22, 2019 - Ball pits used in children’s physical therapy may contribute to germ transmission
March 22, 2019 - Long-term use of inexpensive weight-loss drug may be safe and effective
March 22, 2019 - FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
March 22, 2019 - Anti-Müllerian Hormone Test: MedlinePlus Lab Test Information
March 22, 2019 - Finding the right exercise, diet aids for HIV patients
March 22, 2019 - Health Plans For State Employees Use Medicare’s Hammer On Hospital Bills
March 22, 2019 - Researchers develop new tool for imaging large groups of neurons in living animals
March 22, 2019 - Certain bacteria and immune factors in vagina may cause or protect against preterm birth
March 22, 2019 - Novel breath test could pave new way to non-invasively measure gut health
March 22, 2019 - Pharmaceutical and personal care products may result in new contaminants in waterways
March 22, 2019 - ACC: Catheter Ablation Does Not Cut Mortality, Stroke in A-Fib
March 22, 2019 - Wiedemann-Rautenstrauch syndrome – Genetics Home Reference
March 22, 2019 - Health insurance is not assurance of healthcare
March 22, 2019 - Supporting “curiosity-driven research” at the Discovery Innovation Awards
March 22, 2019 - Must-Reads Of The Week (Some Flying Below The Radar)
March 22, 2019 - Newly engineered nanoscale protein micelles can be tracked by MRI
March 22, 2019 - Pitt engineers win $550,000 NSF CAREER award to develop new intervention for people with ASD
March 22, 2019 - Early discharge does not increase readmission risk for patients after lung surgery
March 22, 2019 - Creating diverse pool of trained scientists to address Alzheimer’s research needs
March 22, 2019 - Surprising discovery offers clues to limit graft-vs.-host disease
March 22, 2019 - Study shows ACA’s positive impact on healthcare affordability and access for women
March 22, 2019 - Study provides new pathway for controlling inflammation
March 22, 2019 - New combination treatment shows promise for common brain tumor in children
March 22, 2019 - Virginia Tech Helmet Lab releases first youth-specific football helmet ratings
March 22, 2019 - New algae-based treatment could reduce need for limb amputation
March 22, 2019 - Stroke risk reduces in both black and white older Medicare beneficiaries, study reports
March 22, 2019 - City of Hope exhibits current studies and data on cancer therapies at AACR
March 22, 2019 - New study identifies CD40 molecule as key entry point for dangerous bacteria
March 22, 2019 - Health Tip: Six Steps to a Healthier Life
March 22, 2019 - even a little activity helps you live longer
March 22, 2019 - Many individuals recovering from addiction continue to suffer from chronic physical disease
March 22, 2019 - New drugs on PBS for Parkinson’s, MND and Cutaneous T cell lymphoma
March 22, 2019 - Saving energy also saves lives, UW-Madison study says
March 22, 2019 - Former inmates who receive social support have better mental health, study finds
March 22, 2019 - Nanofibrous membrane could enhance periodontal tissue regeneration
March 22, 2019 - Anti-vaxxer Italian leader down with chickenpox
March 22, 2019 - Servier collaborates with Harvard researchers to fight metabolic diseases
March 22, 2019 - National Eating Disorders Association
March 22, 2019 - Pumping up red blood cell production
March 22, 2019 - Excessive phosphate fertilizer may hurt plants by altering microbial composition in soil
March 22, 2019 - Medical marijuana laws could be improving older Americans’ health, study suggests
March 22, 2019 - Study indicates the benefits of stopping aspirin in heart attack patients
March 22, 2019 - Deep brain stimulation offers significant relief for patients with treatment-resistant depression
March 22, 2019 - Mental health problems in young adults on the rise
March 22, 2019 - Innovative membrane offers a viable solution for periodontitis
March 22, 2019 - The FDA Grants Rare Pediatric Disease Designation to Odiparcil for the Treatment of MPS VI
March 22, 2019 - insulin therapy: MedlinePlus Medical Encyclopedia
March 22, 2019 - Guidelines on the use of genetic testing in psychiatry
March 22, 2019 - Aspiring Doctors Seek Advanced Training In Addiction Medicine
March 22, 2019 - A change in focus could enable the development of new treatments for Alzheimer’s disease
March 22, 2019 - A new way to visualize the immune cell “landscape” of bowel cancer tumors
March 22, 2019 - Understanding maintenance of quiescent stem cells in chronic myelogenous leukemia
March 22, 2019 - Ludwig scientists to share advances in cancer research at AACR Annual Meeting 2019
March 22, 2019 - Less invasive valve replacement can be safe and effective alternative for healthier patients
March 22, 2019 - Aphasia research reveals new, complex interactions between thought and language
March 22, 2019 - Artificial neural networks can predict how different areas in the brain respond to words
March 22, 2019 - Age-related changes to gut microbiome have adverse impact on vascular health, study shows
March 22, 2019 - Study provides new insight into blood cell and immune cell production
March 22, 2019 - Isolated seniors chat online to prevent cognitive decline
March 22, 2019 - Repurposing drugs to outsmart cancers
March 22, 2019 - Naltrexone implant more effective in reducing relapses in HIV patients with opioid addiction
March 22, 2019 - The Brain Institute wins $7.04 million grant to investigate ‘neurophilosphy of free will’
March 22, 2019 - Karyopharm Announces FDA Extension of Review Period for Selinexor New Drug Application
March 22, 2019 - Eruptive xanthomatosis
March 22, 2019 - Cause of vascular disease in kidney failure reversed in animal model
March 22, 2019 - Researchers discover possible new therapeutic strategy for pancreatic cancer
March 22, 2019 - Ebola spreads to second largest city in DRC
March 22, 2019 - Perivascular spaces contribute to worse cognitive health in older adults
March 22, 2019 - Adolescent daily users more likely to obtain electronic cigarettes from commercial sources
March 22, 2019 - FDA Approves Genentech’s Tecentriq in Combination With Chemotherapy for the Initial Treatment of Adults With Extensive-Stage Small Cell Lung Cancer
March 22, 2019 - Diabetes myths and facts: MedlinePlus Medical Encyclopedia
March 22, 2019 - TGen and ABL pursue global rollout of advanced TB test
March 22, 2019 - Traffic light labels influence people to choose healthier and more sustainable meals
March 22, 2019 - Alzheimer’s patients using antiepileptic drugs have twice the risk of pneumonia, study shows
Researchers discover mechanism on how body’s antimicrobial shield regulates microbiome

Researchers discover mechanism on how body’s antimicrobial shield regulates microbiome

image_pdfDownload PDFimage_print

The microbiome in our intestine plays a vital role in people’s health and the immune system. Any lack of balance there has not only been linked to chronic inflammatory intestinal inflammation, but also type 2 diabetes and other diseases.

A group of researchers at the University Hospital Tübingen has now reported for the first time that they have discovered a mechanism on how the body’s own endogenous antimicrobial defense shield regulates the microbiome and its bacterial composition; the article has been published in a recent edition of “Proceedings” by the National Academy of Science USA” (PNAS). This mechanism provides a fundamental understanding of the structure of the intestinal barrier and host microbial interaction. “It throws open the door for future approaches to new treatments, but also for developing antibiotics and beneficial microbiome modulation,” says the head of the working group, Professor Dr. med. Jan Wehkamp from University Hospital Tübingen.

Cluster bomb effect of defensin HD-5 strengthens the immune system

The researchers discovered a new “cluster bomb” like effect created by the body’s own antibiotics, the so-called defensins (peptides), which are formed and secreted in the Paneth granule cells, in the small intestine. “The HD-5 defensin, which the body produces naturally and releases in the intestine, splinters into fragments if it is exposed to bacteria in the gastrointestinal wall in certain circumstances. These fragments do not, however, consist of ineffective waste, as was thought in the past, but they have an antimicrobial effect against commensal, harmless bacteria and bacteria that are pathogenic,” says Prof. Wehkamp, describing the discovery. The researchers have found 250 new antibiotic combinations in all in the different fragments, when examining them in a laboratory. “This mechanism dramatically increases the antimicrobial spectrum against possible intruders,” Wehkamp adds.

The working group in Tübingen, which has been conducting research into the microbiome for many years, was already able to publish an article in “Nature” in 2011 indicating that defensins play an important role in maintaining the balance between bacteria and the body surfaces in all organisms, particularly in the intestine (but not only there).

The scientists use the latest publication in PNAS to demonstrate how the prevailing conditions inside our intestines affect the activity and structure of the peptides: In reduced conditions with only limited oxygen – a situation that often occurs in the intestine – the HD-5 peptide, which was originally secreted in a folded (oxidized) form, is opened and activated. It becomes more prone to degrading through its new linear structure: As a result, the proteases occurring in the intestinal mucus layer can break up the HD-5 defensin into many fragments – so activating this antimicrobial weapon. Out of one peptide the body creates endless combinations of attacking and controlling microboes which is a very smart and efficient way of defense.

Nothing passes through the HD-6 defensin net

Interestingly, nature has created a completely different defense mechanism in the other Paneth cell defensin peptide – defensin HD-6: In contrast to HD-5 it is protected from any degradation by the proteases because it is able to form an impenetrable net. The scientists report that the HD-6 defensin remains completely stable in the natural gastrointestinal mucus, while HD-5 is broken down into fragments in the same location.

The researchers were able to artificially produce individual fragments of the HD-5 defensin during a following stage and exposed them to different kinds of bacteria. The results were impressive: The fragments demonstrated amazing, variable, antimicrobial activity against harmless and pathogenic bacteria, including gram-negative bacteria, which are notorious for forming resistance to antibiotics.

Greater variety of intestinal flora in mice

The working group in Tübingen was also able to prove that HD-5 fragments affect the composition of bacteria in the intestine of mice and increase the variety of flora in the small intestine. A particular HD-5 fragment was fed to mice orally, for instance – in contrast to a control group, which received normal food. The results were surprising: Administering the fragment led to a higher proportion of akkermansia sp. bacteria in the intestine of the mice. A decrease in the presence of these “good” bacteria had been associated with various diseases like diabetes mellitus and metabolic syndrome in earlier studies. “The fragmentation increases the variability of the antimicrobial defenses, particularly because the initial peptide is one of the most commonly produced and secreted peptides in the whole organism,” says Jan Wehkamp.

Treatment opportunities and new antibiotics

“This pioneer work has opened the door to an entirely new understanding of how host defense functions when confronted by bacteria, but also how the microbiome is regulated. This will be very interesting, as an enormous amount of research work is taking place on the microbiome around the globe,” says Jan Wehkamp, summarizing developments. The discovery made by the group in Tübingen opens up opportunities of finding new antibiotic substances as modulators of the microbiome or new types of antibiotics.

However, the ongoing analysis of fragments of antimicrobial peptides and their role in providing defenses against microorganisms – including possible approaches to treatment for bacteria that are resistant to antibiotics – is only at a very early stage. It is easy to reproduce the fragments discovered by the working group in Tübingen and they could play a role in treating various diseases in the future.

The work of the group, is part of Jan Wehkamp’s Heisenberg Professorship for Innate Immunity at the Medical University Clinic at Tübingen, is also originated as part of the Research Excellence Cluster at the University of Tübingen.

Source:

https://uni-tuebingen.de/

Tagged with:

About author

Related Articles